ilumya

Generic: tildrakizumab-asmn

Labeler: sun pharmaceutical industries, inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name ilumya
Generic Name tildrakizumab-asmn
Labeler sun pharmaceutical industries, inc.
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

tildrakizumab 100 mg/mL

Manufacturer
Sun Pharmaceutical Industries, Inc.

Identifiers & Regulatory

Product NDC 47335-177
Product ID 47335-177_7718538c-3c74-4470-9951-cf9634ab2f31
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761067
Listing Expiration 2026-12-31
Marketing Start 2018-08-06

Pharmacologic Class

Established (EPC)
interleukin-23 antagonist [epc]
Mechanism of Action
interleukin-23 antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 47335177
Hyphenated Format 47335-177

Supplemental Identifiers

RxCUI
2053453 2053458
UNII
DEW6X41BEK
NUI
N0000192799 N0000192798

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ilumya (source: ndc)
Generic Name tildrakizumab-asmn (source: ndc)
Application Number BLA761067 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 100 mg/mL
source: ndc
Packaging
  • 1 mL in 1 SYRINGE, GLASS (47335-177-01)
  • 1 mL in 1 CARTON (47335-177-10)
  • 1 mL in 1 CARTON (47335-177-95)
  • 1 mL in 1 SYRINGE, GLASS (47335-177-96)
source: ndc

Packages (4)

47335-177-01 1 mL in 1 SYRINGE, GLASS (47335-177-01) 47335-177-10 1 mL in 1 CARTON (47335-177-10) 47335-177-95 1 mL in 1 CARTON (47335-177-95) 47335-177-96 1 mL in 1 SYRINGE, GLASS (47335-177-96)

Ingredients (1)

tildrakizumab (100 mg/mL)

Linked Drug Pages (1)

ILUMYA ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "7718538c-3c74-4470-9951-cf9634ab2f31", "openfda": {"nui": ["N0000192799", "N0000192798"], "unii": ["DEW6X41BEK"], "rxcui": ["2053453", "2053458"], "spl_set_id": ["c6a322bb-51b9-4f0e-8642-62a9682ffcde"], "pharm_class_epc": ["Interleukin-23 Antagonist [EPC]"], "pharm_class_moa": ["Interleukin-23 Antagonists [MoA]"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": true, "description": "1 mL in 1 SYRINGE, GLASS (47335-177-01)", "package_ndc": "47335-177-01", "marketing_start_date": "20180806"}, {"sample": true, "description": "1 mL in 1 CARTON (47335-177-10)", "package_ndc": "47335-177-10", "marketing_start_date": "20180806"}, {"sample": false, "description": "1 mL in 1 CARTON (47335-177-95)", "package_ndc": "47335-177-95", "marketing_start_date": "20180806"}, {"sample": false, "description": "1 mL in 1 SYRINGE, GLASS (47335-177-96)", "package_ndc": "47335-177-96", "marketing_start_date": "20180806"}], "brand_name": "ILUMYA", "product_id": "47335-177_7718538c-3c74-4470-9951-cf9634ab2f31", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Interleukin-23 Antagonist [EPC]", "Interleukin-23 Antagonists [MoA]"], "product_ndc": "47335-177", "generic_name": "tildrakizumab-asmn", "labeler_name": "Sun Pharmaceutical Industries, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ILUMYA", "active_ingredients": [{"name": "TILDRAKIZUMAB", "strength": "100 mg/mL"}], "application_number": "BLA761067", "marketing_category": "BLA", "marketing_start_date": "20180806", "listing_expiration_date": "20261231"}